Search Site
Cancer Genetics

ONCOSEQ DNALAB COMPREHENSIVE BRCA1-BRCA2 PANELS

ONCOSEQ DNALAB COMPREHENSIVE BRCA1-BRCA2 PANELS

  • HEREDITER PANEL
  • LIQUID BIOPSY PANEL
  • TEXTURE PANEL

The BRCA1 and BRCA2 genes are tumor suppressor genes that suppress uncontrolled cell growth. Defects in these genes lead to uncontrolled cell proliferation and an increased risk of cancer in various organs. Located on chromosome 17, the BRCA1 and BRCA2 genes are involved in cell growth, cell division and DNA damage repair. BRCA1 and BRCA2 gene mutations are the most important hereditary mutation risk factors for the development of breast and ovarian cancer. Mutations in these genes cause breast-ovarian cancer syndrome. Approximately 6% of breast cancers and 20% of ovarian cancers are caused by mutations in these genes. In cancer patients with BRCA mutations, the response to chemotherapy is better than in patients without these mutations and therefore treatment success is higher.

  • BRCA1
  • BRCA2
  • TP53
  • CDH1
  • PTEN
  • PALB2

  • Test:
    Comprehensive BRCA1-BRCA2 Testing
  • Method:
    Next Generation Sequencing
  • Analysis Time:
    14-21 Days
  • Sample Type:
    FFPE (Tissue), Blood (EDTA), cfDNA
  • Storage Conditions:
    1 week at +4 C
  • Transport Conditions:
    The same day; At room temperature
  • Rejection Criteria:
    Hemolyzed, Lipemic, Icteric samples are not accepted

Discover Your Genetic Heritage

You can contact us to get information about our genetic tests, consultancy services and more.

Contact us

ONCOSEQ DNALAB (Cancer Genetics)

PRIMIS Non-Invasive Prenatal Test

Preimplantation Genetic Diagnosis (PGD)

Whole Exome Sequencing

Clinical Exome Sequencing

Rare Diseases

Carrier Panels - SMARİS